Předmět: |
|
Zdroj: |
Cancer Weekly; 8/20/2024, p421-421, 1p |
Abstrakt: |
A recent study conducted by researchers at the University of Massachusetts has shed light on the role of androgen receptor splice variants in driving the metastatic progression of castration-resistant prostate cancer (CRPC). The study focused on the AR-V7 splice variant and found that it activates distinct transcriptional programs that are involved in epithelial-mesenchymal transition and metastasis. The researchers also discovered that phosphorylation of AR-V7 at Ser81 enhances its pro-metastasis function. These findings provide molecular insights into the mechanisms underlying the development and progression of CRPC. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|